R. Hoetelmans

发表

Assessment of the steady‐state pharmacokinetic interaction between etravirine administered as two different formulations and tenofovir disoproxil fumarate in healthy volunteers

M. Schöller-Gyüre, G. de Smedt, F. Aharchi, 2009, HIV medicine.

Sanctuary sites in HIV-1 infection.

R. Hoetelmans, 1998, Antiviral therapy.

The effect of ﬂuconazole on ritonavir and saquinavir pharmacokinetics in HIV-1-infected individuals

J. Beijnen, D. Burger, P. Koopmans, 2001 .

Combination of Protease Inhibitors for the Treatment of HIV-1-Infected Patients: A Review of Pharmacokinetics and Clinical Experience

J. Beijnen, J. Mulder, J. Lange, 2000, Antiviral therapy.

Antiretroviral drug level monitoring: the next routine test in HIV management?

R. Hoetelmans, 1999, Current opinion in infectious diseases.

The pharmacokinetic (PK) interaction between omeprazole and TMC278, an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI)

M. Stevens, A. Buelens, K. Boven, 2008 .

Pharmacology of antiretroviral drugs.

R. Hoetelmans, 1999, Antiviral Therapy.

Pharmacokinetic (PK) and pharmacodynamic analyses of once- and twice-daily darunavir/ritonavir (DRV/r) in the ODIN trial

T. van de Casteele, V. Sekar, P. Vis, 2010, Journal of the International AIDS Society.

Combined dapsone and clofazimine intoxication

J. Beijnen, C. Koks, J. Otten, 1996, Human & experimental toxicology.